Clinical Trial Update: Concentration- Versus Body Surface Area-based HIPEC in Colorectal Peritoneal Carcinomatosis' Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial comparing concentration-based HIPEC versus body surface area-based HIPEC for colorectal peritoneal carcinomatosis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Peritoneal Carcinomatosis

Snippet

Sponsor: Hasselt University | Conditions: Colorectal Peritoneal Carcinomatosis | Phase 3 | Status: UNKNOWN